Several signaling pathways, such as PI3K, MEK [375], Notch [376], Nrf2 [377], WNT/β-catenin [378], and Hh [379], have been described to regulate the behavior of LCSCs and contribute to radioresistance in NSCLC. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.